On the public citation graph

Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER-medicare database

0 signed · 578 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.269.23.3015openalex-snapshot
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
inferredcites →https://doi.org/10.1002/cncr.11427openalex-snapshot
Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection
inferredcites →https://doi.org/10.1002/cncr.24687openalex-snapshot
Metabolic syndrome and hepatocellular carcinoma
inferredcites →https://doi.org/10.1002/hep.20734openalex-snapshot
Prevalence of and Risk Factors for Nonalcoholic Fatty Liver Disease: The Dionysos Nutrition and Liver Study * #
inferredcites →https://doi.org/10.1002/hep.20973openalex-snapshot
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
inferredcites →https://doi.org/10.1002/hep.21327openalex-snapshot
Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡
inferredcites →https://doi.org/10.1002/hep.22310openalex-snapshot
Cholangiocarcinoma
inferredcites →https://doi.org/10.1002/hep.23527openalex-snapshot
the Incidence and Risk Factors of Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis
inferredcites →https://doi.org/10.1002/hep.23594openalex-snapshot
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
inferredcites →https://doi.org/10.1002/hep.23719openalex-snapshot
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1002/ijc.22283openalex-snapshot
Risk factors for intrahepatic cholangiocarcinoma in a low‐risk population: A nationwide case‐control study
inferredcites →https://doi.org/10.1016/j.amjmed.2006.02.031openalex-snapshot
Metabolic Syndrome and Risk of Cardiovascular Disease: A Meta-Analysis
inferredcites →https://doi.org/10.1016/j.cgh.2005.12.007openalex-snapshot
The Association Between Diabetes and Hepatocellular Carcinoma: A Systematic Review of Epidemiologic Evidence
inferredcites →https://doi.org/10.1016/j.cgh.2007.05.020openalex-snapshot
Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma in the United States: A Population-Based Case-Control Study
inferredcites →https://doi.org/10.1016/j.gtc.2009.12.014openalex-snapshot
The Epidemiology of Obesity
inferredcites →https://doi.org/10.1016/j.jacc.2006.09.032openalex-snapshot
Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death
inferredcites →https://doi.org/10.1016/j.jhep.2004.05.008openalex-snapshot
Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma
inferredcites →https://doi.org/10.1016/j.jhep.2008.10.030openalex-snapshot
Liver biopsy findings from healthy potential living liver donors: Reasons for disqualification, silent diseases and correlation with liver injury tests
inferredcites →https://doi.org/10.1016/j.jhep.2010.04.008openalex-snapshot
A position statement on NAFLD/NASH based on the EASL 2009 special conference
inferredcites →https://doi.org/10.1046/j.1365-2559.2001.01219.xopenalex-snapshot
Pathology and Genetics of Tumours of the Digestive System
inferredcites →https://doi.org/10.1053/j.gastro.2004.07.020openalex-snapshot
Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: A population-based study
inferredcites →https://doi.org/10.1053/j.gastro.2005.04.014openalex-snapshot
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
inferredcites →https://doi.org/10.1053/jhep.2003.50161openalex-snapshot
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
inferredcites →https://doi.org/10.1089/met.2006.0018openalex-snapshot
Is Cholangiocarcinoma Another Complication of Insulin Resistance: A Report of Three Cases
inferredcites →https://doi.org/10.1093/annonc/mdp059openalex-snapshot
Glycemic load in relation to hepatocellular carcinoma among patients with chronic hepatitis infection
inferredcites →https://doi.org/10.1093/jnci/djj234openalex-snapshot
Impact of Classification of Hilar Cholangiocarcinomas (Klatskin Tumors) on the Incidence of Intra- and Extrahepatic Cholangiocarcinoma in the United States
inferredcites →https://doi.org/10.1097/00005650-200208001-00002openalex-snapshot
Overview of the SEER-Medicare Data
inferredcites →https://doi.org/10.1097/01.mlr.0000020942.47004.03openalex-snapshot
Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.
inferredcites →https://doi.org/10.1097/meg.0b013e3282748ef2openalex-snapshot
Primary liver cancers with nonalcoholic steatohepatitis
inferredcites →https://doi.org/10.1111/j.1440-1746.2005.04058.xopenalex-snapshot
Fatty liver and the metabolic syndrome among Shanghai adults
inferredcites →https://doi.org/10.1111/j.1440-1746.2010.06253.xopenalex-snapshot
A fresh look at NASH pathogenesis. Part 1: The metabolic movers
inferredcites →https://doi.org/10.1111/j.1540-4781.1967.tb06731.xopenalex-snapshot
A Position Statement
inferredcites →https://doi.org/10.1159/000282081openalex-snapshot
The Natural History of Non-Alcoholic Fatty Liver Disease
inferredcites →https://doi.org/10.1159/000282085openalex-snapshot
Chemokines as Immune Mediators of Liver Diseases Related to the Metabolic Syndrome
inferredcites →https://doi.org/10.1159/000282094openalex-snapshot
Molecular Mechanisms of Hepatic Fibrosis in Non-Alcoholic Steatohepatitis
inferredcites →https://doi.org/10.1159/000282105openalex-snapshot
Hepatitis C Virus-Induced Steatosis: An Overview
inferredcites →https://doi.org/10.1161/atvbaha.107.151092openalex-snapshot
Metabolic Syndrome Pandemic
inferredcites →https://doi.org/10.1161/circulationaha.109.192644openalex-snapshot
Harmonizing the Metabolic Syndrome
inferredcites →https://doi.org/10.1200/jco.2008.20.7753openalex-snapshot
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
inferredcites →https://doi.org/10.2337/dc08-0423openalex-snapshot
Metabolic Syndrome and Incident Diabetes
inferredcites →https://doi.org/10.2337/diacare.27.10.2444openalex-snapshot
Increasing Prevalence of the Metabolic Syndrome Among U.S. Adults
inferredcites →https://doi.org/10.32388/1bjeusopenalex-snapshot
International Classification of Diseases for Oncology
inferredcites →https://doi.org/10.5858/132.11.1761openalex-snapshot
Does Nonalcoholic Fatty Liver Disease Predispose Patients to Hepatocellular Carcinoma in the Absence of Cirrhosis?
inferredcites →https://doi.org/10.7326/0003-4819-143-10-200511150-00009openalex-snapshot
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4810702openalex-extracted
Metabolic Syndrome is Linked to Overall Cancer Incidence
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2019.6412openalex-snapshot
Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis
inferred← citeshttps://doi.org/10.1002/9781118464557.ch30openalex-snapshot
Uncommon Hepatobiliary Tumors
inferred← citeshttps://doi.org/10.1002/9781118512074.ch109openalex-snapshot
Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/9781118556153.ch17openalex-snapshot
Non‐Alcoholic Fatty Liver Disease, Hepatocellular Cancer, and Other Cancers
inferred← citeshttps://doi.org/10.1002/9781118556153.ch23openalex-snapshot
Metabolic Factors and Steatosis in Patients with Hepatitis B and C
inferred← citeshttps://doi.org/10.1002/9781118589199.ch90openalex-snapshot
Hepatobiliary Cancer
inferred← citeshttps://doi.org/10.1002/9781119000822.hfcm092.pub2openalex-snapshot
Primary Neoplasms of the Liver
inferred← citeshttps://doi.org/10.1002/9781119196235.ch30openalex-snapshot
Uncommon Hepatobiliary Tumors
inferred← citeshttps://doi.org/10.1002/9781119436812.ch59openalex-snapshot
Epidemiology of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1002/bjs.8963openalex-snapshot
Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome
inferred← citeshttps://doi.org/10.1002/cncr.27694openalex-snapshot
The risk of hepatocellular carcinoma among individuals with acquired immunodeficiency syndrome in the United States
inferred← citeshttps://doi.org/10.1002/cncr.28209openalex-snapshot
Modified cisplatin/interferon α‐2b/doxorubicin/5‐fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/cncr.29971openalex-snapshot
Population attributable fractions of risk factors for hepatocellular carcinoma in the United States
inferred← citeshttps://doi.org/10.1002/cncr.30365openalex-snapshot
Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: An analysis of SEER‐Medicare data
inferred← citeshttps://doi.org/10.1002/cncr.34541openalex-snapshot
The multidisciplinary management of cholangiocarcinoma
inferred← citeshttps://doi.org/10.1002/hep.24437openalex-snapshot
Metabolic syndrome and liver cancer: Is excess iron the link?
inferred← citeshttps://doi.org/10.1002/hep.24643openalex-snapshot
Metabolic Syndrome Is Also a Risk Factor for Primary Liver Cancer in Patients Younger than 65 Years of Age?
inferred← citeshttps://doi.org/10.1002/hep.24767openalex-snapshot
The TONIC trial: A step forward in treating pediatric nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1002/hep.25536openalex-snapshot
Outcomes of curative treatment for hepatocellular cancer in nonalcoholic steatohepatitis versus hepatitis C and alcoholic liver disease
inferred← citeshttps://doi.org/10.1002/hep.25600openalex-snapshot
V-AKT murine thymoma viral oncogene homolog/mammalian target of rapamycin activation induces a module of metabolic changes contributing to growth in insulin-induced hepatocarcinogenesis
inferred← citeshttps://doi.org/10.1002/hep.25605openalex-snapshot
Antifibrotic role of macrophage migration inhibitory factor: Discovery of an unexpected function
inferred← citeshttps://doi.org/10.1002/hep.25646openalex-snapshot
Diabetes and hepatocellular cancer risk: Not only a matter of hyperglycemia
inferred← citeshttps://doi.org/10.1002/hep.25915openalex-snapshot
New therapeutic paradigm for patients with cirrhosis
inferred← citeshttps://doi.org/10.1002/hep.26092openalex-snapshot
Risk Factors for Intrahepatic Cholangiocarcinoma: Association Between Metformin Use and Reduced Cancer Risk
inferred← citeshttps://doi.org/10.1002/hep.26661openalex-snapshot
Hepatic Gene Expression Profiles Differentiate Presymptomatic Patients With Mild Versus Severe Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1002/hep.26986openalex-snapshot
Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.
inferred← citeshttps://doi.org/10.1002/hep.28123openalex-snapshot
Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009
inferred← citeshttps://doi.org/10.1002/hep.28506openalex-snapshot
Atorvastatin and fluvastatin are associated with dose‐dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES
inferred← citeshttps://doi.org/10.1002/hep.28765openalex-snapshot
Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis
inferred← citeshttps://doi.org/10.1002/hep.29660openalex-snapshot
Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies
inferred← citeshttps://doi.org/10.1002/hep.31014openalex-snapshot
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1002/hep.32542openalex-snapshot
NAFLD‐related hepatocellular carcinoma: The growing challenge
inferred← citeshttps://doi.org/10.1002/hep4.1575openalex-snapshot
Hepatocellular Carcinoma in Hispanic Patients: Trends and Outcomes in a Large United States Cohort
inferred← citeshttps://doi.org/10.1002/ijc.30818openalex-snapshot
The association between individual metabolic syndrome components, primary liver cancer and cirrhosis: A study in the Swedish AMORIS cohort
inferred← citeshttps://doi.org/10.1002/ijc.31835openalex-snapshot
Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults
inferred← citeshttps://doi.org/10.1002/ijc.33920openalex-snapshot
Changes in general and central fatness are associated with hepatocellular carcinoma: A Korean nationwide longitudinal study
inferred← citeshttps://doi.org/10.1002/jcb.30252openalex-snapshot
Contribution of organokines in the development of NAFLD/NASH associated hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/jcp.27855openalex-snapshot
Prognostic relevance of miR‐137 and its liver microenvironment regulatory target gene AFM in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1002/jgm.2648openalex-snapshot
In vivo bioluminescent imaging of α‐fetoprotein‐producing hepatocellular carcinoma in the diethylnitrosamine‐treated mouse using recombinant adenoviral vector
inferred← citeshttps://doi.org/10.1002/jhbp.1001openalex-snapshot
Obesity and cholangiocarcinoma: A review of epidemiological and molecular associations
inferred← citeshttps://doi.org/10.1002/jso.24223openalex-snapshot
The association between non‐alcoholic steatohepatitis and intrahepatic cholangiocarcinoma: A hospital based case‐control study
inferred← citeshttps://doi.org/10.1002/mc.22266openalex-snapshot
A biphasic response pattern of lipid metabolomics in the stage progression of hepatitis B virus X tumorigenesis
inferred← citeshttps://doi.org/10.1002/oby.21505openalex-snapshot
Overweight, obesity and the risk of gallbladder and extrahepatic bile duct cancers: A meta‐analysis of observational studies
inferred← citeshttps://doi.org/10.1002/osp4.469openalex-snapshot
Safety and efficacy of pharmacologic weight loss in patients with cirrhosis
inferred← citeshttps://doi.org/10.1002/pds.3367openalex-snapshot
Validation of a coding algorithm to identify patients with hepatocellular carcinoma in an administrative database
inferred← citeshttps://doi.org/10.1002/phar.1704openalex-snapshot
Does Angiotensin‐Converting Enzyme Inhibitor and β‐Blocker Use Reduce the Risk of Primary Liver Cancer? A Case–Control Study Using the UK Clinical Practice Research Datalink
inferred← citeshttps://doi.org/10.1007/978-0-387-09841-8_35openalex-snapshot
Diabetes and Liver Disease
inferred← citeshttps://doi.org/10.1007/978-1-4614-2367-6_1openalex-snapshot
Obesity and Gastrointestinal Cancers: Epidemiology
inferred← citeshttps://doi.org/10.1007/978-3-030-22258-1_1openalex-snapshot
Epidemiology and Risk Factors
inferred← citeshttps://doi.org/10.1007/978-3-030-24432-3_31openalex-snapshot
Liver Cancer
inferred← citeshttps://doi.org/10.1007/978-3-030-65908-0_14openalex-snapshot
Cholangiocarcinoma
inferred← citeshttps://doi.org/10.1007/978-3-030-70936-5_5openalex-snapshot
Clinical Epidemiology of Cholangiocarcinoma
inferred← citeshttps://doi.org/10.1007/978-3-031-79150-5_47openalex-snapshot
Biliary Tract Tumors
inferred← citeshttps://doi.org/10.1007/978-3-319-09614-8_11openalex-snapshot
Alcohol Consumption, Wnt/β-Catenin Signaling, and Hepatocarcinogenesis
inferred← citeshttps://doi.org/10.1007/978-3-319-18741-9_35openalex-snapshot
Diabetes and Liver Disease
inferred← citeshttps://doi.org/10.1007/978-3-319-20538-0_14openalex-snapshot
Hepatic and Extrahepatic Malignancies in NAFLD
inferred← citeshttps://doi.org/10.1007/978-3-319-20538-0_2openalex-snapshot
Global Epidemiology and Risk Factors for Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/978-3-319-20797-1_35-1openalex-snapshot
Diabetes and Liver Disease
inferred← citeshttps://doi.org/10.1007/978-3-319-20797-1_35-2openalex-snapshot
Diabetes and Liver Disease
inferred← citeshttps://doi.org/10.1007/978-3-319-26587-2_164-1openalex-snapshot
Etiology and Pathogenesis of Hepatocellular Carcinoma: Inflammatory and Toxic Causes
inferred← citeshttps://doi.org/10.1007/978-3-319-26956-6_164openalex-snapshot
Etiology and Pathogenesis of Hepatocellular Carcinoma: Inflammatory and Toxic Causes
inferred← citeshttps://doi.org/10.1007/978-3-319-34214-6_27openalex-snapshot
Clinical Features and Clinician’s Diagnostic Approach to Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/978-3-319-42542-9_10openalex-snapshot
Obesity and Liver Cancer
inferred← citeshttps://doi.org/10.1007/978-3-319-50168-0_10openalex-snapshot
Cholangiocarcinoma: Disease Pathogenesis and New Treatment Paradigms
inferred← citeshttps://doi.org/10.1007/978-3-319-54531-8_13openalex-snapshot
Hepatocellular Carcinoma: Epidemiology, Basic Principles of Treatment, and Clinical Data
inferred← citeshttps://doi.org/10.1007/978-3-319-92216-4_14openalex-snapshot
Epidemiology and Pathogenesis of Cholangiocarcinoma
inferred← citeshttps://doi.org/10.1007/978-94-017-7215-0_12openalex-snapshot
Biomarkers for Hepatocellular Carcinoma (HCC): An Update
inferred← citeshttps://doi.org/10.1007/978-981-10-8684-7_6openalex-snapshot
Hepatocellular Carcinoma in Obesity: Finding a Needle in the Haystack?
inferred← citeshttps://doi.org/10.1007/s00106-016-0177-zopenalex-snapshot
Diabetes mellitus als prognostischer Marker beim Oropharynx- und Larynxkarzinom
inferred← citeshttps://doi.org/10.1007/s00117-014-2650-6openalex-snapshot
Epidemiologie und Risikofaktoren des hepatozellulären Karzinoms
inferred← citeshttps://doi.org/10.1007/s00261-017-1209-1openalex-snapshot
Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis
inferred← citeshttps://doi.org/10.1007/s00268-014-2828-0openalex-snapshot
Surgical Outcomes in Patients with Hepatocellular Carcinoma Associated with Metabolic Syndrome
inferred← citeshttps://doi.org/10.1007/s00268-019-04996-yopenalex-snapshot
Short‐ and Long‐Term Outcomes of Liver Resection for Intrahepatic Cholangiocarcinoma Associated with the Metabolic Syndrome
inferred← citeshttps://doi.org/10.1007/s00380-024-02474-7openalex-snapshot
Metabolic syndrome is linked to most cancers incidence
inferred← citeshttps://doi.org/10.1007/s00535-012-0653-5openalex-snapshot
Clinicopathological features of liver injury in patients with type 2 diabetes mellitus and comparative study of histologically proven nonalcoholic fatty liver diseases with or without type 2 diabetes mellitus
inferred← citeshttps://doi.org/10.1007/s00595-012-0308-4openalex-snapshot
Postoperative outcomes of patients with hepatocellular carcinoma negative for all virus-related markers
inferred← citeshttps://doi.org/10.1007/s00595-014-1031-0openalex-snapshot
Intrahepatic cholangiocarcinoma and cholangiolocellular carcinoma in cirrhosis and chronic viral hepatitis
inferred← citeshttps://doi.org/10.1007/s10549-011-1790-xopenalex-snapshot
A retrospective review of the metabolic syndrome in women diagnosed with breast cancer and correlation with estrogen receptor
inferred← citeshttps://doi.org/10.1007/s10552-013-0167-3openalex-snapshot
Asbestos: a hidden player behind the cholangiocarcinoma increase? Findings from a case–control analysis
inferred← citeshttps://doi.org/10.1007/s10620-013-2984-3openalex-snapshot
Molecular Evolution of Genetic Susceptibility to Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1007/s10620-014-3180-9openalex-snapshot
Hepatic Steatosis Is Highly Prevalent in Hepatitis B Patients and Negatively Associated with Virological Factors
inferred← citeshttps://doi.org/10.1007/s10620-015-3821-7openalex-snapshot
Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience
inferred← citeshttps://doi.org/10.1007/s10620-018-5165-6openalex-snapshot
Effect of Metabolic Syndrome on the Clinical Outcomes of Chronic Hepatitis B Patients with Nucleos(t)ide Analogues Treatment
inferred← citeshttps://doi.org/10.1007/s10620-020-06053-4openalex-snapshot
Differential Survival Impact of Diabetes Mellitus on Hepatocellular Carcinoma: Role of Staging Determinants
inferred← citeshttps://doi.org/10.1007/s10654-013-9767-1openalex-snapshot
The association between frequency of vigorous physical activity and hepatobiliary cancers in the NIH-AARP Diet and Health Study
inferred← citeshttps://doi.org/10.1007/s11033-014-3302-7openalex-snapshot
Expression of GLP-1R protein and its clinical role in intrahepatic cholangiocarcinoma tissues
inferred← citeshttps://doi.org/10.1007/s11033-021-06962-1openalex-snapshot
Personalized circulating tumor DNA in patients with hepatocellular carcinoma: a pilot study
inferred← citeshttps://doi.org/10.1007/s11307-021-01578-0openalex-snapshot
Dynamic Contrast-Enhanced Ultrasound Radiomics for Hepatocellular Carcinoma Recurrence Prediction After Thermal Ablation
inferred← citeshttps://doi.org/10.1007/s11377-012-0648-zopenalex-snapshot
Diagnostik und Früherkennung des hepatozellulären Karzinoms
inferred← citeshttps://doi.org/10.1007/s11377-014-0940-1openalex-snapshot
HCC‐Früherkennung bei Patienten mit chronischen Lebererkrankungen
inferred← citeshttps://doi.org/10.1007/s11377-016-0095-3openalex-snapshot
Leberresektion vs. Lebertransplantation bei HCC
inferred← citeshttps://doi.org/10.1007/s11605-013-2149-xopenalex-snapshot
Prevalence of Nonalcoholic Steatohepatitis Among Patients with Resectable Intrahepatic Cholangiocarcinoma
inferred← citeshttps://doi.org/10.1007/s11605-017-3629-1openalex-snapshot
Comparison of Hepatectomy for Patients with Metabolic Syndrome-Related HCC and HBV-Related HCC
inferred← citeshttps://doi.org/10.1007/s11605-021-04926-1openalex-snapshot
Impact of Metabolic Syndrome on Postoperative Outcomes Among Medicare Beneficiaries Undergoing Hepatectomy
inferred← citeshttps://doi.org/10.1007/s11894-014-0412-2openalex-snapshot
The Treatment of Cholangiocarcinoma: a Hepatologist’s Perspective
inferred← citeshttps://doi.org/10.1007/s11901-015-0260-zopenalex-snapshot
Pathogenesis of Hepatocellular Carcinoma Development in Non-alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1007/s11901-017-0331-4openalex-snapshot
Racial/Ethnic Disparities in Hepatocellular Carcinoma Epidemiology
inferred← citeshttps://doi.org/10.1007/s11901-017-0340-3openalex-snapshot
Impact of Non-alcoholic Fatty Liver Disease on Chronic Hepatitis B Infection
inferred← citeshttps://doi.org/10.1007/s12029-021-00728-5openalex-snapshot
An Insight into Cholangiocarcinoma and Recent Advances in its Treatment
inferred← citeshttps://doi.org/10.1007/s12032-013-0806-2openalex-snapshot
Single measurement of hemoglobin predicts outcome of HCC patients
inferred← citeshttps://doi.org/10.1007/s12032-024-02327-3openalex-snapshot
Anti-cancer potential of zerumbone in cancer and glioma: current trends and future perspectives
inferred← citeshttps://doi.org/10.1007/s12072-013-9451-2openalex-snapshot
Insulin resistance: mechanism and implications for carcinogenesis and hepatocellular carcinoma in NASH
inferred← citeshttps://doi.org/10.1007/s12328-012-0284-7openalex-snapshot
Development of a hepatocellular carcinoma in a chronic hepatitis C patient 18 years after achieving a sustained virological response to interferon therapy: case report and literature review
inferred← citeshttps://doi.org/10.1007/s12328-014-0548-5openalex-snapshot
Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies
inferred← citeshttps://doi.org/10.1007/s12672-025-02518-yopenalex-snapshot
Bibliometric visualization of hepatocellular carcinoma and metabolic syndrome research: trends and emerging areas
inferred← citeshttps://doi.org/10.1007/s13139-012-0166-4openalex-snapshot
In Vitro Radionuclide Therapy and In Vivo Scintigraphic Imaging of Alpha-Fetoprotein-Producing Hepatocellular Carcinoma by Targeted Sodium Iodide Symporter Gene Expression
inferred← citeshttps://doi.org/10.1007/s13277-014-1858-4openalex-snapshot
Development of a novel score for early detection of hepatocellular carcinoma among high-risk hepatitis C virus patients
inferred← citeshttps://doi.org/10.1007/s13277-014-1939-4openalex-snapshot
Obesity and the risk of cholangiocarcinoma: a meta-analysis
inferred← citeshttps://doi.org/10.1007/s40471-019-00188-3openalex-snapshot
The Changing Epidemiology of Primary Liver Cancer
inferred← citeshttps://doi.org/10.1007/s40618-017-0799-3openalex-snapshot
NAFLD/NASH in patients with type 2 diabetes and related treatment options
inferred← citeshttps://doi.org/10.1016/b978-0-12-801238-3.65865-8openalex-snapshot
Cholangiocarcinoma
inferred← citeshttps://doi.org/10.1016/b978-0-323-37591-7.00047-1openalex-snapshot
Cholangiocarcinoma
inferred← citeshttps://doi.org/10.1016/b978-0-323-42873-6.00033-0openalex-snapshot
Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/b978-0-323-90965-5.00002-7openalex-snapshot
Obesity and cancers of the liver, gallbladder, and pancreas
inferred← citeshttps://doi.org/10.1016/b978-0-323-99283-1.00010-0openalex-snapshot
Theranostic and precision medicine for the diagnosis of hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/b978-0-443-26711-6.00041-xopenalex-snapshot
Malignant liver tumors
inferred← citeshttps://doi.org/10.1016/bs.acr.2022.02.001openalex-snapshot
Inflammatory pathways and cholangiocarcinoma risk mechanisms and prevention
inferred← citeshttps://doi.org/10.1016/j.acra.2023.03.001openalex-snapshot
Radiological Quantification of Sarcopenic Obesity and its Role in Chronic Liver Disease Severity
inferred← citeshttps://doi.org/10.1016/j.ajpath.2018.01.012openalex-snapshot
Fatty Acid Binding Protein 4 (FABP4) Overexpression in Intratumoral Hepatic Stellate Cells within Hepatocellular Carcinoma with Metabolic Risk Factors
inferred← citeshttps://doi.org/10.1016/j.amjmed.2016.12.029openalex-snapshot
Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome
inferred← citeshttps://doi.org/10.1016/j.amjms.2020.04.031openalex-snapshot
Nonalcoholic Fatty Liver Disease Associated With Bladder Cancer
inferred← citeshttps://doi.org/10.1016/j.aohep.2019.06.014openalex-snapshot
Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis
inferred← citeshttps://doi.org/10.1016/j.aohep.2019.07.004openalex-snapshot
Obesity and liver cancer
inferred← citeshttps://doi.org/10.1016/j.aohep.2019.11.001openalex-snapshot
Ruptured hepatocellular carcinoma and non-alcoholic fatty liver disease, a potentially life-threatening complication in a population at increased risk
inferred← citeshttps://doi.org/10.1016/j.aohep.2022.100737openalex-snapshot
Clinical treatment of cholangiocarcinoma: an updated comprehensive review
inferred← citeshttps://doi.org/10.1016/j.bbadis.2017.11.026openalex-snapshot
Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment
inferred← citeshttps://doi.org/10.1016/j.bpg.2015.02.003openalex-snapshot
Epidemiology of cholangiocarcinoma
inferred← citeshttps://doi.org/10.1016/j.canep.2013.03.006openalex-snapshot
Type II diabetes and metabolic syndrome in relation to head and neck squamous cell carcinoma risk: A SEER-Medicare database study
inferred← citeshttps://doi.org/10.1016/j.canlet.2012.01.038openalex-snapshot
Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.canlet.2013.08.036openalex-snapshot
Non-viral causes of liver cancer: Does obesity led inflammation play a role?
inferred← citeshttps://doi.org/10.1016/j.canlet.2015.09.008openalex-snapshot
Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management
inferred← citeshttps://doi.org/10.1016/j.ccell.2017.05.009openalex-snapshot
Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma
inferred← citeshttps://doi.org/10.1016/j.cgh.2011.08.005openalex-snapshot
Abstracts from Around the World
inferred← citeshttps://doi.org/10.1016/j.cgh.2013.02.017openalex-snapshot
Association Between Markers of Obesity and Progression From Barrett's Esophagus to Esophageal Adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.cgh.2013.07.040openalex-snapshot
Insulin Resistance, Obesity, and Liver Cancer
inferred← citeshttps://doi.org/10.1016/j.cgh.2014.10.011openalex-snapshot
Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Associated Cirrhosis Awaiting Liver Transplants
inferred← citeshttps://doi.org/10.1016/j.chest.2021.12.667openalex-snapshot
Risk of Cardiovascular Toxicity According to Tumor Laterality Among Older Patients With Early Stage Non-small Cell Lung Cancer Treated With Radiation Therapy
inferred← citeshttps://doi.org/10.1016/j.cld.2013.09.001openalex-snapshot
Obesity and Liver Cancer
inferred← citeshttps://doi.org/10.1016/j.cld.2013.09.008openalex-snapshot
Impact of Nutrition and Obesity on Chronic Liver Disease
inferred← citeshttps://doi.org/10.1016/j.cld.2013.09.015openalex-snapshot
The Impact of Obesity and Metabolic Syndrome on Chronic Hepatitis B and Drug-Induced Liver Disease
inferred← citeshttps://doi.org/10.1016/j.cld.2017.08.014openalex-snapshot
Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.cld.2020.08.001openalex-snapshot
Obesity Management of Liver Transplant Waitlist Candidates and Recipients
inferred← citeshttps://doi.org/10.1016/j.cld.2024.06.007openalex-snapshot
Alcohol and Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.clinre.2014.07.001openalex-snapshot
miR-21 expression predicts prognosis in hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.clinre.2019.01.009openalex-snapshot
Incretin-based treatment in type 2 diabetes mellitus and risk of cholangiocarcinoma: Is it only adverse drug effect?
inferred← citeshttps://doi.org/10.1016/j.clinre.2021.101836openalex-snapshot
A woman presenting with an unusual cause of fulminant liver failure and sepsis
inferred← citeshttps://doi.org/10.1016/j.cpsurg.2020.100854openalex-snapshot
Surgical management of biliary malignancy
inferred← citeshttps://doi.org/10.1016/j.diii.2017.01.014openalex-snapshot
Diagnosis of hepatocellular carcinoma: An update on international guidelines
inferred← citeshttps://doi.org/10.1016/j.dld.2014.09.020openalex-snapshot
Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
inferred← citeshttps://doi.org/10.1016/j.dld.2014.12.010openalex-snapshot
Patients with chronic hepatitis C without advanced fibrosis and hepatocellular carcinoma: A retrospective clinical–pathological study
inferred← citeshttps://doi.org/10.1016/j.dld.2017.01.147openalex-snapshot
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
inferred← citeshttps://doi.org/10.1016/j.dld.2021.12.002openalex-snapshot
Association of metabolic health phenotypes, obesity, and hepatocellular carcinoma risk
inferred← citeshttps://doi.org/10.1016/j.dsx.2017.12.021openalex-snapshot
Characterization and prevalence of metabolic syndrome among overweight and obese young Palestinian students at An-Najah National University
inferred← citeshttps://doi.org/10.1016/j.dsx.2017.12.023openalex-snapshot
Metabolic syndrome prevalence in the Iranian adult’s general population and its trend: A systematic review and meta-analysis of observational studies
inferred← citeshttps://doi.org/10.1016/j.ejca.2013.06.002openalex-snapshot
Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.ejca.2021.06.052openalex-snapshot
Persistent status of metabolic syndrome and risk of cholangiocarcinoma: A Korean nationwide population-based cohort study
inferred← citeshttps://doi.org/10.1016/j.ejca.2023.03.005openalex-snapshot
Anthropometric indicators of adiposity and risk of primary liver cancer: A systematic review and dose–response meta-analysis
inferred← citeshttps://doi.org/10.1016/j.ejim.2016.08.019openalex-snapshot
Metabolic syndrome, obesity, and the risk of cancer development
inferred← citeshttps://doi.org/10.1016/j.envres.2015.09.027openalex-snapshot
Pesticide exposure and hepatocellular carcinoma risk: A case-control study using a geographic information system (GIS) to link SEER-Medicare and California pesticide data
inferred← citeshttps://doi.org/10.1016/j.exger.2025.112802openalex-snapshot
Metabolic syndrome and cancer risk: A bidirectional two-sample Mendelian randomization study
inferred← citeshttps://doi.org/10.1016/j.gene.2016.03.011openalex-snapshot
Identification and differential expression of microRNAs associated with fat deposition in the liver of Wistar rats with nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1016/j.hpb.2019.04.007openalex-snapshot
Expanding the Liver Imaging Reporting and Data System (LI-RADS) v2018 diagnostic population: performance and reliability of LI-RADS for distinguishing hepatocellular carcinoma (HCC) from non-HCC primary liver carcinoma in patients who do not meet strict LI-RADS high-risk criteria
inferred← citeshttps://doi.org/10.1016/j.hpb.2020.05.005openalex-snapshot
Hepatocellular carcinoma in patients with no identifiable risk factors
inferred← citeshttps://doi.org/10.1016/j.humpath.2015.07.018openalex-snapshot
Steatohepatitic variant of hepatocellular carcinoma in the absence of metabolic syndrome or background steatosis: a clinical, pathological, and genetic study
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2020.12.009openalex-snapshot
Tyrosine kinase inhibitors and their unique therapeutic potentialities to combat cancer
inferred← citeshttps://doi.org/10.1016/j.ijsu.2017.01.110openalex-snapshot
Clinical characteristics and prognosis of non-B, non-C hepatocellular carcinoma: The impact of patient sex on disease-free survival - A retrospective cohort study
inferred← citeshttps://doi.org/10.1016/j.jbior.2012.04.002openalex-snapshot
PI3K keeps the balance between metabolism and cancer
inferred← citeshttps://doi.org/10.1016/j.jchirv.2019.08.004openalex-snapshot
Syndrome métabolique et chirurgie hépatique
inferred← citeshttps://doi.org/10.1016/j.jconrel.2025.02.008openalex-snapshot
Cutting-edge biotherapeutics and advanced delivery strategies for the treatment of metabolic dysfunction-associated steatotic liver disease spectrum
inferred← citeshttps://doi.org/10.1016/j.jecr.2018.07.001openalex-snapshot
Two cases of cholangiocarcinoma in diabetes mellitus causing worsening of glycemic control and acute liver dysfunction
inferred← citeshttps://doi.org/10.1016/j.jep.2025.121147openalex-snapshot
The Central Qi theory in traditional Chinese medicine: Gut microbiota modulation as a strategic target for hepatocellular carcinoma therapy
inferred← citeshttps://doi.org/10.1016/j.jff.2021.104389openalex-snapshot
The advantages of using Scutellaria baicalensis and its flavonoids for the management of non-viral hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.jfma.2021.10.014openalex-snapshot
Hepatic steatosis and development of type 2 diabetes: Impact of chronic hepatitis B and viral specific factors
inferred← citeshttps://doi.org/10.1016/j.jhep.2011.11.009openalex-snapshot
Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: Results from ANRS CO13 HEPAVIH
inferred← citeshttps://doi.org/10.1016/j.jhep.2012.02.022openalex-snapshot
Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma
inferred← citeshttps://doi.org/10.1016/j.jhep.2013.06.008openalex-snapshot
Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma
inferred← citeshttps://doi.org/10.1016/j.jhep.2014.01.021openalex-snapshot
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
inferred← citeshttps://doi.org/10.1016/j.jhep.2014.08.013openalex-snapshot
Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C
inferred← citeshttps://doi.org/10.1016/j.jhep.2014.11.011openalex-snapshot
Sorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretion
inferred← citeshttps://doi.org/10.1016/j.jhep.2015.01.024openalex-snapshot
Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC
inferred← citeshttps://doi.org/10.1016/j.jhep.2017.10.008openalex-snapshot
NAFLD and cancer: More cause for concern?
inferred← citeshttps://doi.org/10.1016/j.jhep.2019.09.007openalex-snapshot
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.jhep.2022.08.030openalex-snapshot
Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease
inferred← citeshttps://doi.org/10.1016/j.jhepr.2024.101075openalex-snapshot
Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndrome
inferred← citeshttps://doi.org/10.1016/j.jnha.2024.100261openalex-snapshot
Burden of liver cancer attributable to high fasting plasma glucose: a global analysis based on the global burden of disease study 2019
inferred← citeshttps://doi.org/10.1016/j.jss.2018.08.004openalex-snapshot
Publisher's Note
inferred← citeshttps://doi.org/10.1016/j.jss.2018.11.008openalex-snapshot
Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.jviscsurg.2019.11.004openalex-snapshot
Metabolic syndrome and hepatic surgery
inferred← citeshttps://doi.org/10.1016/j.lanepe.2024.101171openalex-snapshot
Mapping the landscape of biliary tract cancer in Europe: challenges and controversies
inferred← citeshttps://doi.org/10.1016/j.mayocp.2012.09.017openalex-snapshot
Metabolic Syndrome as a Risk Factor for Barrett Esophagus: A Population-Based Case-Control Study
inferred← citeshttps://doi.org/10.1016/j.mcna.2016.06.010openalex-snapshot
Nutrition Interventions for Chronic Liver Diseases and Nonalcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.1016/j.med.2020.06.020openalex-snapshot
Colangiocarcinoma
inferred← citeshttps://doi.org/10.1016/j.metabol.2014.01.011openalex-snapshot
Obesity-associated mechanisms of hepatocarcinogenesis
inferred← citeshttps://doi.org/10.1016/j.metabol.2022.155342openalex-snapshot
Metabolic profile predicts incident cancer: A large-scale population study in the UK Biobank
inferred← citeshttps://doi.org/10.1016/j.rcl.2026.01.004openalex-snapshot
Early Detection of Gallbladder and Biliary Malignancy
inferred← citeshttps://doi.org/10.1016/j.respe.2013.11.073openalex-snapshot
Cancer incidence and mortality in France over the 1980–2012 period: Solid tumors
inferred← citeshttps://doi.org/10.1016/j.soc.2014.09.001openalex-snapshot
Epidemiology of Hepatocellular Carcinoma
inferred← citeshttps://doi.org/10.1016/j.soc.2019.06.012openalex-snapshot
Biliary Tract and Primary Liver Tumors
inferred← citeshttps://doi.org/10.1016/j.soc.2025.12.006openalex-snapshot
Minimally Invasive / Robotic Surgery for Hepatobiliary Cancer
showing the first 200 of 534 · page through all 534
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.